12 studies found for:    Open Studies | Heart Diseases | UCSD OR UC San Diego OR VA San Diego
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions
Conditions: Coronary Artery Disease;   Coronary Disease;   Myocardial Ischemia;   Heart Diseases;   Cardiovascular Diseases;   Arteriosclerosis;   Arterial Occlusive Diseases;   Vascular Diseases
Intervention: Procedure: CorPath-assisted Percutaneous Coronary Intervention
2 Recruiting AC6 Gene Transfer for CHF
Condition: Congestive Heart Failure
Interventions: Drug: Ad5.hAC6;   Drug: Sucrose (3%)
3 Recruiting The Dynamics of Human Atrial Fibrillation
Conditions: Atrial Fibrillation;   Atrial Tachyarrhythmia
Intervention:
4 Not yet recruiting Substrate Versus Trigger Ablation for Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: FIRM Ablation;   Procedure: Conventional AF ablation with PVI
5 Unknown  Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction
Conditions: Ranolazine;   Diastolic Heart Failure;   Tissue Doppler Ultrasound;   Echocardiography
Intervention: Drug: ranolazine
6 Recruiting An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM)
Condition: Ischemic Dilated Cardiomyopathy (IDCM)
Interventions: Biological: ixmyelocel-T;   Other: Vehicle Control
7 Recruiting Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Condition: Cardiac Arrest
Interventions: Drug: amiodarone;   Drug: Lidocaine;   Other: Normal saline
8 Recruiting Effectiveness Study of Circumferential vs. Segmental Ablation in Paroxysmal Atrial Fibrillation
Condition: Paroxysmal Atrial Fibrillation
Intervention:
9 Not yet recruiting Nit-Occlud PDA Post-Approval Study
Condition: Patent Ductus Arteriosus (PDA)
Intervention:
10 Recruiting MAESTRO (Macitentan in Eisenmenger Syndrome To Restore Exercise Capacity)
Condition: Eisenmenger Syndrome
Interventions: Drug: Macitentan 10 mg, oral tablet, to be taken once daily.;   Drug: Matching placebo oral tablet, to be taken once daily.
11 Recruiting Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.
Condition: Smoking Cessation
Interventions: Drug: placebo;   Drug: varenicline tartrate;   Drug: bupropion hydrochloride;   Drug: Nicotine Replacement Therapy Patch
12 Recruiting Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial
Condition: Portopulmonary Hypertension
Intervention: Drug: Ambrisentan

Indicates status has not been verified in more than two years